In late June 2026, Recursion Pharmaceuticals, Inc. was added to multiple Russell value and small-cap benchmarks, including ...

Recursion Pharmaceuticals has been trying to rebuild momentum after a steep five year decline in shareholder returns, yet its ...

That admission is what some in the field call recursive self-improvement (RSI), the point at which large language models ...

How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...

Customer stories Events & webinars Ebooks & reports Business insights GitHub Skills ...

Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company that combines automation, artificial intelligence, machine learning, and in vivo validation capabilities to discover novel ...

The second edition of the Reply AI Music Contest, the international competition created by Reply to explore new forms of expression combining artificial intelligence, music and live performance, ...

Michael Burry warns the AI trade looks like “mass addiction” as semiconductor stocks soar and SOXX valuations near 15-year ...

Alongside this rapid progress, an equally ambitious effort has emerged to construct ethical frameworks for intelligent ...

Vitalik Buterin has published an updated long-term roadmap for Ethereum, calling the multi-year effort “Lean Ethereum” as the network’s biggest redesign since the Merge. He posted it to X on July 4, ...